Variant report
Variant | esv3391238 |
---|---|
Chromosome Location | chr21:37890368-37890851 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs5843766 | chr21:37890373-37890374 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs201304875 | chr21:37890374-37890375 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71198821 | chr21:37890384-37890385 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs3030072 | chr21:37890403-37890404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs57527435 | chr21:37890407-37890408 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183317029 | chr21:37890417-37890418 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187860000 | chr21:37890426-37890427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551412542 | chr21:37890484-37890485 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569642980 | chr21:37890604-37890605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200745288 | chr21:37890619-37890620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551638413 | chr21:37890620-37890621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11701001 | chr21:37890621-37890622 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs527585136 | chr21:37890625-37890626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547433681 | chr21:37890649-37890650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs5027467 | chr21:37890653-37890654 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs377345632 | chr21:37890725-37890726 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143890530 | chr21:37890749-37890750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556720237 | chr21:37890762-37890763 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11909629 | chr21:37890805-37890806 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs190740937 | chr21:37890811-37890812 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559130811 | chr21:37890817-37890818 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572606213 | chr21:37890823-37890824 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs567363081 | chr21:37890831-37890832 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs77297711 | chr21:37890834-37890835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs541722744 | chr21:37890846-37890847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Down syndrome | 17412756 | CNVD |
Down syndrome | 17576883 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Seminomas | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 19156837 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Melanoma | 18172304 | CNVD |
Autism | 22958593 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Wilms tumour | 21544195 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Ovarian cancer | 22174824 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Mental retardation | 21031080 | CNVD |
Polymicrogyria | 21031080 | CNVD |
periventricular nodular heterotopia | 21031080 | CNVD |
Myelodysplastic syndrome | 21606161 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Autism | 18414403 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21858162 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17899364 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Down syndrome | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Down syndrome | 21154855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr21:37883200-37895000 | Weak transcription | Placenta Amnion | Placenta Amnion |
2 | chr21:37888600-37891600 | Weak transcription | Primary B cells from cord blood | blood |
3 | chr21:37888800-37891000 | Weak transcription | Primary B cells from peripheral blood | blood |
4 | chr21:37890000-37892400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
5 | chr21:37890200-37890400 | Flanking Active TSS | GM12878-XiMat | blood |
6 | chr21:37890400-37891000 | Enhancers | GM12878-XiMat | blood |